-The Hindu Over 5,000 violations pertains to distracting ‘part-screen’ and ‘scrolling’ ads The Electronic Media Monitoring Centre (EMMC) of the Information and Broadcasting Ministry has reported 13,000 instances of violations of regulatory norms by television channels in 2013-14. These violations came to light after Guntur-based Edara Gopi Chand, an activist with Media-Watch India, waged a three-year battle to expose the poor regulation of content on India’s TV channels. Using the RTI Act, Mr....
More »SEARCH RESULT
Total Matching Records found : 50
Patients' groups voice patent fears
-The Telegraph New Delhi: Health and patients' rights groups have called on the government to resist American pressure that they claimed was aimed at weakening safeguards in India's patent laws that allow drug companies to sell inexpensive generic medicine. Health activists representing patients' rights said they were concerned that bilateral talks on intellectual property rights, to feature during US President Barack Obama's visit to India beginning this weekend, may be rigged against...
More »Wither Away the Pressure on India's Patent Law -Saradindu Bhaduri
-Vikalp Once again, India is under pressure from the US to revise its patent law. Anyone familiar with the activities of the United States Trade Representatives (USTR) would know that this is nothing new. It has been among the USTR's primary mandates to use trade restrictions in order to persuade (to put it mildly) countries to strengthen their IPR laws. There is, however, a qualitative difference between the actions it has...
More »Access denied -Kundan Pandey
-Down to Earth Shortage of antiretroviral drugs and lack of diagnosis is not new in India, but government does not admit to the crisis The fight against HIV/AIDS in India is becoming tougher by the day as patients continue to face an acute shortage of antiretroviral drugs. This is an alarming situation for a country with the third-highest number of HIV+ people in the world-2.1 million. In 2012, about 140,000 people in...
More »Supreme Court refuses to hear challenge on NPPA decision -Apoorva
-Livemint The petition challenged NPPA's decision of withdrawing its internal guideline to set prices of non-essential drugs New Delhi: The Supreme Court on Monday refused to entertain a petition challenging a decision by the country's drug price regulator to withdraw its internal guideline to set prices of non-essential drugs. Earlier this year, the National Pharmaceutical Pricing Authority (NPPA) issued a guideline empowering itself to cap the prices of 108 non-essential drugs, attracting...
More »
